Prosecution Insights
Last updated: September 17, 2026

Endo Biologics Limited

4 pending office actions • 2 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready

Portfolio Summary

4
Total Pending OAs
3
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

2
Hard (50%)
2
Medium (50%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only1 (25%)
§103 only1 (25%)
Double-patenting + other1 (25%)
Multi-statute (no §101)1 (25%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

3
Life Sciences
75% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
1
Business / Other
25% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

40 h
Manual time on pending OAs
8 h
Time saved (low, 20%)
14 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
TSAY, MARSHA M 1 45.7% +52.7%
DICKENS, AMELIA NICOLE 1 47.6% +21.1%
BARRON, SEAN C 1 53.0% +30.8%
BOWERS, ERIN M 1 54.7% +10.6%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18763509 COMPOSITIONS AND METHODS FOR PRODUCING CLOSTRIDIAL COLLAGENASES BARRON, SEAN C —
18662818 COMPOSITIONS AND METHODS FOR TREATING COLLAGEN-MEDIATED DISEASES BOWERS, ERIN M —

Interview Candidates (4)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
19288143 Methods Of Treating Plantar Fibromatosis TSAY, MARSHA M —
19174127 Treatment Of Uterine Fibroids Using Purified Collagenase DICKENS, AMELIA NICOLE —
18763509 COMPOSITIONS AND METHODS FOR PRODUCING CLOSTRIDIAL COLLAGENASES BARRON, SEAN C —
18662818 COMPOSITIONS AND METHODS FOR TREATING COLLAGEN-MEDIATED DISEASES BOWERS, ERIN M —

Top Art Units

Art UnitApps
1653 2
1656 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19288143 Methods Of Treating Plantar Fibromatosis TSAY, MARSHA M 1656 §103 Non-Final OA — Pending Aug 01, 2025
19174127 Treatment Of Uterine Fibroids Using Purified Collagenase DICKENS, AMELIA NICOLE — §103§112DP Non-Final OA — Pending Apr 09, 2025
18763509 COMPOSITIONS AND METHODS FOR PRODUCING CLOSTRIDIAL COLLAGENASES BARRON, SEAN C 1653 §101 Final Rejection — Pending Jul 03, 2024
18662818 COMPOSITIONS AND METHODS FOR TREATING COLLAGEN-MEDIATED DISEASES BOWERS, ERIN M 1653 §103§112 Non-Final OA — Pending May 13, 2024

Managing Endo Biologics Limited's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month